Thrombosed AV grafts

Not indicated for use in Canada.

Arteriovenous (AV) access grafts that have thrombosed are often associated with worse outcomes than those that are stenosed1

  • The 2019 KDOQI guidelines for vascular access specify a target goal of ≤ three interventions annually to maintain access2:

    • In support of achieving this goal, KDOQI recommends stent grafts in preference to angioplasty alone for recurrent thrombotic AV access lesions.

There are a limited number of randomized trials to help guide evidence-based treatment decisions for patients with thrombosed grafts

  • In the Gore REVISE Clinical Study, 43% of patients in the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface*† arm of the study enrolled with a thrombosed graft.1 
angiogram

Before

Treatment of stenosis at the venous anastomosis of a synthetic graft.

Images courtesy of Thomas Ward, M.D. Used with permission.

Read the full case study

angiogram

After

Post-placement of 8 mm x 7.5 cm GORE® VIABAHN® Endoprosthesis.

Images courtesy of Thomas Ward, M.D. Used with permission.

Read the full case study

The GORE® VIABAHN® Endoprosthesis has proven success when treating thrombosed grafts1, 2 

Proven patency

  • Exceeded KDOQI minimum guidelines for three-month circuit primary patency for thrombotic patients (48%) whereas percutaneous transluminal angioplasty (PTA) did not (39%).1,2
  • Increased primary patency in thrombosed grafts of both the target lesion and the circuit by ~50% when compared to PTA at six months.1

Fewer reinterventions

  • Lowered the mean number of interventions over two years by 40% in thrombosed grafts.3

AV access maintenance challenges

  • The GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface† has proven success in the most challenging AV access cases, including early PTA failures, lesions at points of flexion, and in thrombosed grafts.

Learn more.

* As used by Gore, Heparin Bioactive Surface refers to Gore’s proprietary CBAS® Heparin Surface.

† Also referred to as the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface in some regions.

  1. Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. Journal of Vascular Surgery 2016;64(5):1400-1410.e1. http://www.sciencedirect.com/science/article/pii/S0741521416301756
  2. Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. American Journal of Kidney Diseases 2020;75(4)Supplement 2:S1-S164.
  3. Mohr BA, Sheen AL, Roy-Chaudhury P, Schultz SR, Aruny JE; REVISE Investigators.  Clinical and economic benefits of stent grafts in dysfunctional and thrombosed hemodialysis access graft circuits in the REVISE Randomized Trial.  Journal of Vascular & Interventional Radiology 2019;30(2):203-211.e4.

Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly

eIFU Symbol

22797544-EN

Residents of some states have the right to opt-out of the “sharing” or “selling” of their personal information. Gore does not "sell" the personal information of website users. Gore may "share" the personal information of website users, as standard advertising practice meant to offer you a more personalized service.

If you want to opt-out from Gore “sharing” your personal information, click on Opt-Out of Sharing to turn off the targeting cookies that we share with our advertising partners in order to provide you with personalized information. Disabling sharing will stop the use of cookies to targeted advertising but you may still see generic Gore ads.

Please note that your exercising of the rights outlined will have no adverse effect on the price and quality of our goods or services.

Opt-Out of Sharing

You Have Successfully Opted Out of the Sharing of Your Personal Information

Please note that if you clear your cookies and then use another device or browser, etc. your opt-out status is not transferred to the new device or browser.